![7th Annual USC Multi-Disciplinary Breast Cancer Symposium](http://media.vumedi.com/thumbs/channel_logo/2019/10/6ad17b02-7558-4a93-843d-1f7cb605f5d9.png.200x0_q85.jpg)
7th Annual USC Multi-Disciplinary Breast Cancer Symposium
Combined Inhibition of Endocrine Therapy and the PI3K/AKT/mTOR Pathways Appears Superior to Either Component in HR+ Metastatic Breast Cancer
283 views
May 27, 2020
Comments 0
Login to view comments.
Click here to Login
Videos